يعرض 1 - 10 نتائج من 12 نتيجة بحث عن '"Rare Diseases/therapy"', وقت الاستعلام: 0.90s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المصدر: Acta Clinica Belgica, 79 (1), 26 - 33 (2024-02)

    Relation: https://www.tandfonline.com/doi/pdf/10.1080/17843286.2023.2280737; urn:issn:1784-3286; urn:issn:2295-3337

  2. 2
  3. 3
  4. 4

    المؤلفون: Fulvio Mavilio

    المساهمون: Approches génétiques intégrées et nouvelles thérapies pour les maladies rares (INTEGRARE), École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université d'Évry-Val-d'Essonne (UEVE)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Généthon, École Pratique des Hautes Études (EPHE)

    المصدر: Gene Ther
    Gene Ther, 2017, 24 (9), pp.590-592. ⟨10.1038/gt.2017.36⟩

  5. 5

    المساهمون: BMC, BMC, Department of Public Health [Ghent, Belgium], Institut du Cerveau et de la Moëlle Epinière = Brain and Spine Institute (ICM), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), EURORDIS-Rare Diseases Europe (Bureau de Paris), EURORDIS - Plateforme Maladies Rares [Paris], Institute of Population Health Sciences and Informatics [Edinburgh, Scotland, U.K.], University of Edinburgh, The Swedish Delegation to the Nordic Council [Stockholm, Sweden], Swedish Parliament [Stockholm, Sweden], Centre for Research on Health and Social Care Management [Milan, Italy] (CERGAS), Bocconi University [Milan, Italy], Ospedale San Raffaele Scientific Institute [Milan, Italy], Fondazione IRCCS Instituto Nazionale dei Tumori [Milan, Italy], Health Economics [Heidelberg, Germany], Heidelberg University, Division of Health Economics [Heidelberg, Germany], German Cancer Research Center - Deutsches Krebsforschungszentrum [Heidelberg] (DKFZ), Institute for Innovation & Valuation in Health Care [Wiesbaden, Germany], Pharmaceutical and Public Health Policy [London, UK], University College of London [London] (UCL), Clinical Research [Rome, Italy], Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS San Raffaele Pisana), Clinical Pharmacology and Therapeutic [Barcelona, Spain], Universitat Autònoma de Barcelona (UAB), National Institute for Health and Care Excellence [Manchester, UK] (NICE), Dolon Ltd [London, UK], European government relations and public policy at Celgene [Brussels, Belgium], EUCOPE and Celgene Corporation., Universiteit Gent = Ghent University [Belgium] (UGENT), Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Centre National de la Recherche Scientifique (CNRS)

    المصدر: Orphanet Journal of Rare Diseases
    Orphanet Journal of Rare Diseases, 2016, 12 (1), pp.50. ⟨10.1186/s13023-017-0601-9⟩
    Orphanet Journal of Rare Diseases, BioMed Central, 2016, 12 (1), pp.50. ⟨10.1186/s13023-017-0601-9⟩
    Annemans, L, Aymé, S, Le Cam, Y, Facey, K, Gunther, P, Nicod, E, Reni, M, Roux, J-L, Schlander, M, Taylor, D, Tomino, C, Torrent-Farnell, J, Upadhyaya, S, Hutchings, A & Le Dez, L 2017, ' Recommendations from the European Working Group for Value Assessment and Funding Processes in Rare Diseases (ORPH-VAL) ', Orphanet journal of rare diseases, vol. 12, no. 1, pp. 50 . https://doi.org/10.1186/s13023-017-0601-9

    وصف الملف: application/pdf

  6. 6

    المصدر: Pediatric rheumatology online journal, vol. 14, no. 1, pp. 35

    وصف الملف: application/pdf

  7. 7
  8. 8
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

  9. 9
    دورية أكاديمية
  10. 10